Impact of COVID-19 pandemic on surgical volume and outcomes in a terciary care center in Brazil.


Journal

Revista do Colegio Brasileiro de Cirurgioes
ISSN: 1809-4546
Titre abrégé: Rev Col Bras Cir
Pays: Brazil
ID NLM: 7809515

Informations de publication

Date de publication:
2024
Historique:
received: 28 10 2023
accepted: 22 02 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 8 5 2024
Statut: epublish

Résumé

COVID-19 pandemic led to a sharp decline in surgical volume worldwide due to the postponement of elective procedures. This study evaluated the impact of COVID-19 pandemic in surgical volumes and outcomes of abdominal surgery in high-risk patients requiring intensive care unit admission. patients admitted for postoperative care were retrospectively evaluated. Data concerning perioperative variables and outcomes were compared in two different periods: January 2017-December 2019 and January 2020-December 2022, respectively, before (period I) and after (period II) the onset of COVID-19 pandemic. 1.402 patients (897 women, mean age 62+17 years) were investigated. Most of the patients underwent colorectal (n=393) and pancreato-biliary (n=240) surgery, 52% of elective procedures. Surgical volume was significantly lower in period II (n=514) when compared to period I (n= 888). No recovery was observed in the number of surgical procedures in 2022 (n=135) when compared to 2021(n=211) and 2020 (n=168). Subjects who underwent abdominal surgery in period II had higher Charlson comorbidity index (4,85+3,0 vs. 4,35+2,8, p=0,002), more emergent/urgent procedures (51% vs. 45%, p=0,03) and more clean-contaminated wounds (73,5% vs. 66,8%, p=0,02). A significant decrease in the volume of colorectal surgery was also observed (24% vs, 31%, p<0,0001) after the onset of COVID-19 pandemic, 125 (8,9%) died, no deaths due to COVID-19 infection. Mortality was higher in period II when compared to period I (11% vs. 8%, p=0,08). COVID-19 pandemic was associated with a decrease in surgical volume of high-risk patients without apparent recovery in recent years. No influence of COVID-19 was noted in postoperative mortality.

Sections du résumé

BACKGROUNDS BACKGROUND
COVID-19 pandemic led to a sharp decline in surgical volume worldwide due to the postponement of elective procedures. This study evaluated the impact of COVID-19 pandemic in surgical volumes and outcomes of abdominal surgery in high-risk patients requiring intensive care unit admission.
METHODS METHODS
patients admitted for postoperative care were retrospectively evaluated. Data concerning perioperative variables and outcomes were compared in two different periods: January 2017-December 2019 and January 2020-December 2022, respectively, before (period I) and after (period II) the onset of COVID-19 pandemic.
RESULTS RESULTS
1.402 patients (897 women, mean age 62+17 years) were investigated. Most of the patients underwent colorectal (n=393) and pancreato-biliary (n=240) surgery, 52% of elective procedures. Surgical volume was significantly lower in period II (n=514) when compared to period I (n= 888). No recovery was observed in the number of surgical procedures in 2022 (n=135) when compared to 2021(n=211) and 2020 (n=168). Subjects who underwent abdominal surgery in period II had higher Charlson comorbidity index (4,85+3,0 vs. 4,35+2,8, p=0,002), more emergent/urgent procedures (51% vs. 45%, p=0,03) and more clean-contaminated wounds (73,5% vs. 66,8%, p=0,02). A significant decrease in the volume of colorectal surgery was also observed (24% vs, 31%, p<0,0001) after the onset of COVID-19 pandemic, 125 (8,9%) died, no deaths due to COVID-19 infection. Mortality was higher in period II when compared to period I (11% vs. 8%, p=0,08).
CONCLUSIONS CONCLUSIONS
COVID-19 pandemic was associated with a decrease in surgical volume of high-risk patients without apparent recovery in recent years. No influence of COVID-19 was noted in postoperative mortality.

Identifiants

pubmed: 38716917
pii: S0100-69912024000100204
doi: 10.1590/0100-6991e-20243678-en
pii:
doi:

Types de publication

Journal Article

Langues

eng por

Sous-ensembles de citation

IM

Pagination

e20243678

Auteurs

Paulo Lisboa Bittencourt (PL)

- Hospital Português, Unidade de Gastroenterologia e Hepatologia - Salvador - BA - Brasil.
- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Gabriel Vianna Pereira Aragão (GVP)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Murilo Tavares Valverde Filho (MT)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Guilherme Almeida Farias Amorim (GAF)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Igor Lima Vieira DE Castro (ILV)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Jade DE Oliveira Santana (JO)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Laiane Caitano Costa (LC)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Beatriz Soares Marques Muniz (BSM)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Vivian Roberta Soares Silva (VRS)

- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Liana Codes (L)

- Hospital Português, Unidade de Gastroenterologia e Hepatologia - Salvador - BA - Brasil.
- Escola Bahiana de Medicina e Saúde Pública, Departamento de Gastroenterologia - Salvador - BA - Brasil.

Claudio Celestino Zollinger (CC)

- Hospital Português, Unidade de Gastroenterologia e Hepatologia - Salvador - BA - Brasil.

Wellington Andraus (W)

- Universidade de São Paulo, Departamento de Gastroenterologia - São Paulo - Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH